                         SEQUENCE LISTING

<110>  Ostuka Pharmaceutical Co., Ltd.
 
<120>  BIOMARKERS FOR CANCER THERAPY USING MDM2 ANTAGONISTS

<130>  P48426WO

<150>  GB2013476.3
<151>  2020-08-27

<150>  GB2020493.9
<151>  2020-12-23

<160>  3     

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCT primer

<400>  1
ggtgaaaccc cgtctctact                                                   20


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  PCR primer

<400>  2
ggttcaagcg attctcctgc                                                   20


<210>  3
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Hydrolysis probe

<400>  3
cgcccggcta atttttgtat                                                   20


